FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2929112109> ?p ?o ?g. }

• W2929112109 endingPage "2481" @default.
• W2929112109 startingPage "2465" @default.
• W2929112109 abstract "Considering that Aurora kinase inhibitors are currently under clinical investigation in hematologic cancers, the identification of molecular events that limit the response to such agents is essential for enhancing clinical outcomes. Here, we discover a NF-κB-inducing kinase (NIK)-c-Abl-STAT3 signaling-centered feedback loop that restrains the efficacy of Aurora inhibitors in multiple myeloma. Mechanistically, we demonstrate that Aurora inhibition promotes NIK protein stabilization via downregulation of its negative regulator TRAF2. Accumulated NIK converts c-Abl tyrosine kinase from a nuclear proapoptotic into a cytoplasmic antiapoptotic effector by inducing its phosphorylation at Thr735, Tyr245 and Tyr412 residues, and, by entering into a trimeric complex formation with c-Abl and STAT3, increases both the transcriptional activity of STAT3 and expression of the antiapoptotic STAT3 target genes PIM1 and PIM2. This consequently promotes cell survival and limits the response to Aurora inhibition. The functional disruption of any of the components of the trimer NIK-c-Abl-STAT3 or the PIM survival kinases consistently enhances the responsiveness of myeloma cells to Aurora inhibitors. Importantly, concurrent inhibition of NIK or c-Abl disrupts Aurora inhibitor-induced feedback activation of STAT3 and sensitizes myeloma cells to Aurora inhibitors, implicating a combined inhibition of Aurora and NIK or c-Abl kinases as potential therapies for multiple myeloma. Accordingly, pharmacological inhibition of c-Abl together with Aurora resulted in substantial cell death and tumor regression in vivo The findings reveal an important functional interaction between NIK, Abl and Aurora kinases, and identify the NIK, c-Abl and PIM survival kinases as potential pharmacological targets for improving the efficacy of Aurora inhibitors in myeloma." @default.
• W2929112109 created "2019-04-11" @default.
• W2929112109 creator A5010690912 @default.
• W2929112109 creator A5012195468 @default.
• W2929112109 creator A5013619928 @default.
• W2929112109 creator A5020575257 @default.
• W2929112109 creator A5022887652 @default.
• W2929112109 creator A5026816549 @default.
• W2929112109 creator A5028779780 @default.
• W2929112109 creator A5036214254 @default.
• W2929112109 creator A5038350233 @default.
• W2929112109 creator A5043991877 @default.
• W2929112109 creator A5065500174 @default.
• W2929112109 creator A5069717812 @default.
• W2929112109 creator A5080609494 @default.
• W2929112109 creator A5088484484 @default.
• W2929112109 date "2019-04-04" @default.
• W2929112109 modified "2023-10-10" @default.
• W2929112109 title "Functional interplay between NF-κB-inducing kinase and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma" @default.
• W2929112109 cites W1490283529 @default.
• W2929112109 cites W1886178005 @default.
• W2929112109 cites W1962960638 @default.
• W2929112109 cites W1973562447 @default.
• W2929112109 cites W1974768393 @default.
• W2929112109 cites W1979107490 @default.
• W2929112109 cites W1982327595 @default.
• W2929112109 cites W1983257767 @default.
• W2929112109 cites W1988642004 @default.
• W2929112109 cites W1988720071 @default.
• W2929112109 cites W1990185112 @default.
• W2929112109 cites W1991677162 @default.
• W2929112109 cites W1997577435 @default.
• W2929112109 cites W2006863789 @default.
• W2929112109 cites W2009857052 @default.
• W2929112109 cites W2016878962 @default.
• W2929112109 cites W2017052599 @default.
• W2929112109 cites W2018463161 @default.
• W2929112109 cites W2021520308 @default.
• W2929112109 cites W2026858875 @default.
• W2929112109 cites W2028330103 @default.
• W2929112109 cites W2030865745 @default.
• W2929112109 cites W2036331617 @default.
• W2929112109 cites W2040993067 @default.
• W2929112109 cites W2042872424 @default.
• W2929112109 cites W2046587635 @default.
• W2929112109 cites W2049226990 @default.
• W2929112109 cites W2056172893 @default.
• W2929112109 cites W2059287377 @default.
• W2929112109 cites W2059301162 @default.
• W2929112109 cites W2064299413 @default.
• W2929112109 cites W2075520012 @default.
• W2929112109 cites W2080186620 @default.
• W2929112109 cites W2081107312 @default.
• W2929112109 cites W2084734004 @default.
• W2929112109 cites W2092559416 @default.
• W2929112109 cites W2101117526 @default.
• W2929112109 cites W2107972068 @default.
• W2929112109 cites W2112688349 @default.
• W2929112109 cites W2116767239 @default.
• W2929112109 cites W2117525838 @default.
• W2929112109 cites W2121323579 @default.
• W2929112109 cites W2134748741 @default.
• W2929112109 cites W2137723669 @default.
• W2929112109 cites W2138661872 @default.
• W2929112109 cites W2140697965 @default.
• W2929112109 cites W2143877481 @default.
• W2929112109 cites W2153916767 @default.
• W2929112109 cites W2158287952 @default.
• W2929112109 cites W2160075057 @default.
• W2929112109 cites W2162730852 @default.
• W2929112109 cites W2581841075 @default.
• W2929112109 cites W2747899690 @default.
• W2929112109 cites W2992496655 @default.
• W2929112109 doi "https://doi.org/10.3324/haematol.2018.208280" @default.
• W2929112109 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6959191" @default.
• W2929112109 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30948493" @default.
• W2929112109 hasPublicationYear "2019" @default.
• W2929112109 type Work @default.
• W2929112109 sameAs 2929112109 @default.
• W2929112109 citedByCount "3" @default.
• W2929112109 countsByYear W29291121092021 @default.
• W2929112109 countsByYear W29291121092022 @default.
• W2929112109 countsByYear W29291121092023 @default.
• W2929112109 crossrefType "journal-article" @default.
• W2929112109 hasAuthorship W2929112109A5010690912 @default.
• W2929112109 hasAuthorship W2929112109A5012195468 @default.
• W2929112109 hasAuthorship W2929112109A5013619928 @default.
• W2929112109 hasAuthorship W2929112109A5020575257 @default.
• W2929112109 hasAuthorship W2929112109A5022887652 @default.
• W2929112109 hasAuthorship W2929112109A5026816549 @default.
• W2929112109 hasAuthorship W2929112109A5028779780 @default.
• W2929112109 hasAuthorship W2929112109A5036214254 @default.
• W2929112109 hasAuthorship W2929112109A5038350233 @default.
• W2929112109 hasAuthorship W2929112109A5043991877 @default.
• W2929112109 hasAuthorship W2929112109A5065500174 @default.
• W2929112109 hasAuthorship W2929112109A5069717812 @default.
• W2929112109 hasAuthorship W2929112109A5080609494 @default.
• W2929112109 hasAuthorship W2929112109A5088484484 @default.

• next